About this Episode
Dr Adam Brufsky from the University of Pittsburgh discusses the latest clinical data on HER2-targeted therapy for the management of HER2-positive localized breast cancer.
CME information and select publications here.
Dr Adam Brufsky from the University of Pittsburgh discusses the latest clinical data on HER2-targeted therapy for the management of HER2-positive localized breast cancer.
CME information and select publications here.